AstraZeneca Buys St. Louis Vaccine Startup Omniose After Three-Year Research Deal
Source: gencat cat / Wikimedia CommonsA small vaccine developer with roots in St. Louis's biotech incubator scene is now part of one of the world's biggest pharmaceutical companies. AstraZeneca has acquired Omniose, the Central West End biotech working on vaccines against…